Navigation Links
Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
Date:12/14/2009

MORRISTOWN, N.J., Dec. 14 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced a new program encouraging health professionals to help maintain the bone health of prostate cancer patients who are on long-term androgen deprivation therapy (ADT). Nearly two million men are receiving ADT, a palliative treatment for prostate cancer that, while highly effective and considered the "gold therapy," can cause bone loss and increase a man's risk for osteoporosis.

As part of the program, Watson is providing urologists, oncologists and other health professionals with free 30-day supplies of calcium and vitamin D supplements along with educational patient brochures on how to help maintain bone health in men with prostate cancer on ADT.

Each supplement tablet contains 600 mg of calcium and 400 IU of vitamin D, and when taken twice daily, can help prostate cancer patients meet the daily amounts recommended by the National Osteoporosis Foundation (NOF) and the National Comprehensive Cancer Network (NCCN) for adult men 50 years of age or older.

"The bone health side effects of long-term ADT are a serious issue, yet few cancer patients are being informed about this risk or about the lifestyle changes and drug therapy that can help prevent bone loss," said Neal Shore, MD, FACS, CPI, Medical Director at the Carolina Urologic Research Center. "Because men with prostate cancer are more often receiving their care from a urologist or oncologist, it is important that specialists are educating their male patients about bone health rather than assuming it is the responsibility of the general practitioner."

Androgen deprivation therapy - the use of synthetic luteinizing hormone releasing hormone analogs (LHRH) therapy - is an effective and commonly used long-term therapeutic option for treati
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Present at Credit Suisse Healthcare Conference
8. Watson Files FDA Application for Generic Rozerem(R)
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014  According to the American ... children spend on digital devices. An AOA survey reports ... 10 and 17 estimate they use an electronic device ... separate AOA survey of parents revealed that only 40 ... device for that same amount of time. Eye doctors ...
(Date:7/22/2014)... , July 22, 2014 Quantum Materials Corporation (OTCQB:QTMM) ... Mr. John Heaton to the Board of Directors. QMC ... Ghassan Jabbour , QMC Chief Science Officer and Board of ... Wong of Rice University and Mr. Tomio Gotoh , ... . " Quantum Materials welcomes two new ...
(Date:7/21/2014)... -- Champions Oncology (OTC: CSBR), a company engaged in the ... the development and use of oncology drugs, today announced ... the fourth quarter and fiscal year ended April 30, ... The company will host a conference call ... EDT (1:30 p.m. PDT). To participate in the call, ...
Breaking Medicine Technology:Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4
... May 5, 2011 IRIDEX Corporation (Nasdaq: IRIX ) ... sales and improved financial results for the first quarter ended April ... $0.06 per diluted share, up from $0.5 million or $0.05 per ... ophthalmology sales grew 10%. Total sales increased to $11.2 million ...
... Inc. (Nasdaq: BIOD ) today reported financial results for ... Fiscal Year 2011 Financial Results Biodel reported a net ... million, or $0.21 per share, compared to a net loss of ... the prior year. Research and development expenses were ...
Cached Medicine Technology:IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 2IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 3IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 4IRIDEX Reports Growing Revenue and Profits in 2011 First Quarter 5Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 2Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 3Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 4Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 5Biodel Reports Second Quarter Fiscal Year 2011 Financial Results 6
(Date:7/22/2014)... July 22, 2014 For more than ... cold storage consumers with dynamic, specialized humidification ... customer satisfaction. Offering 50-70% less energy requirements than ... This process is completed through a non-chemical procedure ... also provide a 4.2 Micron droplet. The size ...
(Date:7/22/2014)... Texas (PRWEB) July 22, 2014 For ... Advocate Foundation (PAF) have been working in tandem to ... insurance options, facilitate access to care, and help survivors ... 2014, the two foundations expanded their partnership to include ... by cancer deal with the other practical, emotional, and ...
(Date:7/22/2014)... Get Real Health announced today a ... (IDF) to provide their patient community with a new ... electronically track their symptoms, medications and other health-related information—enabling ... allow those patients and families who want to ... shared with the U.S. Immunodeficiency Network (USIDNET) registry, ...
(Date:7/22/2014)... Atreo Services will be presenting its full ... and accessories in booth #1423 at the American Society ... in Chicago, Ill., Aug. 3-6. , Atreo will display ... as well as its selection of liners and inserts ... In addition, representatives will be available to talk ...
(Date:7/22/2014)... Altec Products, Inc. , a leader ... their Gold Sponsorship of Sage Summit 2014 ... and Casino in Las Vegas, Nevada. The largest educational ... in taking advantage of the many opportunities to network ... and educate themselves on the latest enterprise resource planning ...
Breaking Medicine News(10 mins):Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 2Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 3Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3
... -- Women may be less likely to develop premenstrual syndrome ... B vitamins, a new study suggests. Women who ... reduced their risk of PMS, the data suggested. Thiamine ... and researchers said eating two to three servings of thiamine-rich ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, March 14 ... is, a pediatrician or nurse they see regularly who offers comprehensive ... needs met, new research finds. Yet it,s the sickest children ... require the most care -- who are less likely to get ...
... for healthier humans around the globe are making headway ... diarrheal illness, according to research from the Frederick S. ... Denver,s (DU) Josef Korbel School of International Studies. ... a series of five volumes that focus on human ...
... 14, 2011The first human studies of an oral drug regimen ... near 50% reduction in HIV incidence, but a number of ... be implemented on a large scale, according to an article ... journal published by Mary Ann Liebert, Inc. ( www.liebertpub.com ). ...
... Education recently received a five year, $3.7 million grant ... to fund a project aimed at preventing obesity among ... mothers simple yet authoritative strategies to promote appropriate food ... was awarded to Jenifer Orlet Fisher, associate professor of ...
... National Institute of Allergy and Infectious Diseases (NIAID), part ... the O157:H7 strain of Escherichia coli causes ... The bacterium secretes a protein called NleH1 that directs ... responses. This process not only helps the bacterium evade ...
Cached Medicine News:Health News:Diets Rich in Vitamin B May Help Prevent PMS, Study Finds 2Health News:'Medical Homes' Help Kids Get Comprehensive Care 2Health News:'Medical Homes' Help Kids Get Comprehensive Care 3Health News:DU researchers find that headway being made fighting communicable diseases globally 2Health News:DU researchers find that headway being made fighting communicable diseases globally 3Health News:Early success of anti-HIV preventive oral drug regimen is promising, but questions remain 2Health News:Temple receives $3.7 million to study parenting styles' effect on childhood obesity 2
Take Performance to a Higher Level....
Rapid Exchange Stent Delivery System...
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
... The EVS has an ergonomic ... activated mechanism which requires a ... gently locks onto the target ... the site before, during and ...
Medicine Products: